HUMAN ANTIBODY AGAINST RABIES VIRUS AND PHARMACEUTICAL COMPOSITION THEREOF

PROBLEM TO BE SOLVED: To provide an antibody having new epitope-recognizing specificity for attaining the diagnoses, prevention and/or treatments of symptoms caused by Rabies-related viruses. SOLUTION: There is provided a rabies virus-resistant monoclonal antibody or its antigen-binding fragment whi...

Full description

Saved in:
Bibliographic Details
Main Authors NISHIZONO AKIRA, NAKAJIMA KANTO, TAKADA KENZO
Format Patent
LanguageEnglish
Published 17.03.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide an antibody having new epitope-recognizing specificity for attaining the diagnoses, prevention and/or treatments of symptoms caused by Rabies-related viruses. SOLUTION: There is provided a rabies virus-resistant monoclonal antibody or its antigen-binding fragment which can specifically bind to Rabies virus (RV) to neutralize its biological activity and binds to an epitope containing the specific amino acid residue of G protein. COPYRIGHT: (C)2011,JPO&INPIT
Bibliography:Application Number: JP20090199962